Benralizumab in the management of rare primary eosinophilic lung diseases. Griscti Soler D, Bennici A, Brunetto S, Gangemi S, et al. Allergy Asthma Proc 2022;43:494-500.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Griscti Soler D, Bennici A, Brunetto S, Gangemi S, et al. Benralizumab in the management of rare primary eosinophilic lung diseases. Allergy Asthma Proc 2022;43:494-500.
PMID: 36335418